JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3051
Enlight Renewable Energy
ENLT
$9.31B
| $4.61M | ﹤0.01% |
240,861
-575,031
| -70% | -$9M |
2023 Q1
3 quarters
|
|
|
ECO
3052
Okeanis Eco Tankers
ECO
$3.41B
| $4.6M | ﹤0.01% |
+171,603
| New | +$4.55M |
2023 Q4
0 quarters
|
|
3053
Amphastar Pharmaceuticals
AMPH
$1.08B
| $4.59M | ﹤0.01% |
74,225
-6,324
| -8% | -$332K |
2014 Q3
37 quarters
|
|
|
SHYM
3054
iShares Short Duration High Yield Muni Active ETF
SHYM
$811M
| $4.59M | ﹤0.01% |
+207,516
| New | +$4.35M |
2023 Q4
0 quarters
|
|
3055
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.78B
| $4.58M | ﹤0.01% |
344,001
-142,807
| -29% | -$2.05M |
2021 Q1
11 quarters
|
|
3056
Virtu Financial
VIRT
$5.19B
| $4.56M | ﹤0.01% |
225,079
+19,205
| +9% | +$354K |
2020 Q1
15 quarters
|
|
|
AVNS
3057
DELISTED
Avanos Medical
AVNS
| $4.56M | ﹤0.01% |
203,228
-44,311
| -18% | -$915K |
2014 Q4
36 quarters
|
|
3058
TG Therapeutics
TGTX
$8.31B
| $4.56M | ﹤0.01% |
266,768
+62,218
| +30% | +$723K |
2016 Q4
28 quarters
|
|
3059
PUT
Synchrony
SYF
$23.4B
| $4.55M | ﹤0.01% |
119,100
+105,600
| +782% | +$3.34M |
2023 Q3
1 quarter
|
|
|
DOCU
3060
CALL
DocuSign
DOCU
$12.9B
| $4.55M | ﹤0.01% |
76,500
+2,000
| +3% | +$91.7K |
2022 Q3
5 quarters
|
|
3061
PUT
Buckle
BKE
$2.21B
| $4.53M | ﹤0.01% |
+95,400
| New | +$3.61M |
2023 Q4
0 quarters
|
|
3062
Hilltop Holdings
HTH
$2.2B
| $4.51M | ﹤0.01% |
128,018
+7,217
| +6% | +$218K |
2013 Q2
42 quarters
|
|
3063
Supernus Pharmaceuticals
SUPN
$2.47B
| $4.51M | ﹤0.01% |
155,753
+21,930
| +16% | +$581K |
2015 Q4
32 quarters
|
|
|
VSTO
3064
DELISTED
Vista Outdoor Inc.
VSTO
| $4.51M | ﹤0.01% |
152,429
+33,239
| +28% | +$915K |
2015 Q1
35 quarters
|
|
3065
iShares Short Maturity Bond ETF
NEAR
$5.1B
| $4.5M | ﹤0.01% |
89,025
-18,219
| -17% | -$912K |
2022 Q4
4 quarters
|
|
|
ACH
3066
Accendra Health
ACH
$38.9M
| $4.49M | ﹤0.01% |
233,228
+88,951
| +62% | +$1.61M |
2013 Q2
42 quarters
|
|
3067
Calamos Strategic Total Return Fund
CSQ
$3.28B
| $4.49M | ﹤0.01% |
302,161
+295,923
| +4,744% | +$4.13M |
2022 Q4
4 quarters
|
|
3068
Ligand Pharmaceuticals
LGND
$6.04B
| $4.49M | ﹤0.01% |
62,879
+2,664
| +4% | +$157K |
2015 Q4
32 quarters
|
|
3069
Northwest Bancshares
NWBI
$2.22B
| $4.49M | ﹤0.01% |
359,416
+77,394
| +27% | +$862K |
2015 Q4
32 quarters
|
|
|
AIV
3070
Aimco
AIV
$280M
| $4.49M | ﹤0.01% |
572,850
-139,122
| -20% | -$939K |
2013 Q2
42 quarters
|
|
3071
Compass Diversified
CODI
$822M
| $4.49M | ﹤0.01% |
199,783
+44,668
| +29% | +$875K |
2015 Q4
32 quarters
|
|
3072
CALL
Pultegroup
PHM
$22B
| $4.48M | ﹤0.01% |
43,400
| – | – |
2023 Q2
2 quarters
|
|
3073
Chegg
CHGG
$81.9M
| $4.47M | ﹤0.01% |
393,672
+99,623
| +34% | +$945K |
2013 Q4
40 quarters
|
|
|
CSGS
3074
DELISTED
CSG Systems International
CSGS
| $4.47M | ﹤0.01% |
83,930
+29,405
| +54% | +$1.51M |
2013 Q2
42 quarters
|
|
3075
Canadian Solar
CSIQ
$760M
| $4.45M | ﹤0.01% |
169,756
+163,671
| +2,690% | +$3.61M |
2013 Q3
41 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.